ClinConnect ClinConnect Logo
Search / Trial NCT06586021

Evaluation of the Aortoseal™ for Sealing and Fixation of AAA Endovascular Grafts to Aortic Wall

Launched by ENDORON MEDICAL · Sep 3, 2024

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a new device called the Aortoseal Endostapling System, which is designed to help securely attach a special type of graft (a tube used to repair blood vessels) to the wall of the aorta in patients with an abdominal aortic aneurysm (AAA). An AAA is a condition where the aorta, the main blood vessel supplying blood to the body, becomes enlarged and can be at risk of bursting. The trial is currently recruiting participants aged 65 to 74 who either have a qualifying AAA that can be treated with an endovascular graft or have already received one in the past.

If you or a loved one are considering participation, you can expect to undergo treatment involving this new device, which aims to ensure a better and more secure fit of the graft to the aorta. This could potentially lead to improved outcomes for patients with AAA. Participants will be closely monitored throughout the trial, and it's a chance to contribute to research that may benefit future patients.

Gender

ALL

Eligibility criteria

  • Subjects diagnosed with a qualifying AAA suitable for elective endovascular repair with Endovascular Graft System or have a previously placed endovascular graft.

About Endoron Medical

Endoron Medical is a pioneering clinical trial sponsor dedicated to advancing innovative medical solutions through rigorous research and development. With a focus on enhancing patient outcomes, Endoron Medical specializes in the development of cutting-edge therapeutic technologies and interventions across various medical fields. The organization is committed to maintaining the highest standards of clinical integrity and regulatory compliance, fostering collaborations with healthcare professionals and institutions to ensure the safe and effective delivery of its products. By prioritizing patient-centric approaches, Endoron Medical aims to drive transformative changes in healthcare through evidence-based practices and rigorous clinical trials.

Locations

Chicago, Illinois, United States

Dallas, Texas, United States

Plano, Texas, United States

Norfolk, Virginia, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported